2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 178484041, compound

HRID 2271752Notes

Reaction equation

HRID 2271752 reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][CH2:18][C@H:19]1[CH2:24][CH2:23][C@H:22]([N:25]([CH3:27])[CH3:26])[CH2:21][CH2:20]1.[Cl:28][C:29]1[CH:34]=[C:33](B2OC(C)(C)C(C)(C)O2)[CH:32]=[C:31]([Cl:44])[C:30]=1[OH:45]>>[CH:14]1([C:12]([C:6]2[CH:7]=[N:8][C:9]3[C:4]([C:5]=2[NH:17][CH2:18][C@H:19]2[CH2:20][CH2:21][C@H:22]([N:25]([CH3:27])[CH3:26])[CH2:23][CH2:24]2)=[CH:3][C:2]([C:33]2[CH:34]=[C:29]([Cl:28])[C:30]([OH:45])=[C:31]([Cl:44])[CH:32]=2)=[CH:11][CH:10]=3)=[O:13])[CH2:15][CH2:16]1

Participants

3

Procedure

Following general procedure F, (6-bromo-4-{[trans-4-(dimethylamino)cyclohexyl]methylamino}quinolin-3-yl)(cyclopropyl)methanone (66 mg, 0.153 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (65 mg, 0.230 mmol) to afford the desired product (38 mg, 50%) as a yellow solid: 1H NMR (300 MHz, CD3OD+Acetic Acid-d4) δ 9.24 (s, 1H), 8.49 (d, J=1.7 Hz, 1H), 8.10 (dd, J=8.8, 1.8 Hz, 1H), 7.95 (d, J=8.8 Hz, 1H), 7.68 (s, 2H), 3.90 (d, J=6.5 Hz, 2H), 2.85 (d, J=11.2 Hz, 6H), 2.15 (t, J=11.3 Hz, 4H), 2.01-1.74 (m, 2H), 1.61 (dd, J=21.6, 12.1 Hz, 2H), 1.46-1.07 (m, 7H); ESI MS m/z 512 [C28H31Cl2N3O2+H]+; HPLC 99.0% (AUC), tR=10.65 min.

Sources & evidence

ORD record
ord-e19f60574e38434e8b4bb02dbc190df8
Source dataset
uspto-grants-2015_09
Patent number
US09120749B2

Reaction notes

Loading…